COLUMBUS, Ohio, Feb. 20, 2018 -- Washington Prime Group Inc. (NYSE:WPG) today announced that the Company’s Board of Directors declared a quarterly cash dividend on its common shares and operating partnership units. A cash dividend of $0.25 per common share and operating partnership unit was declared. The dividend is payable on March 15, 2018 to shareholders and operating partnership unit holders of record on March 5, 2018.
In addition, the Board of Directors declared quarterly cash dividends of $0.4688 per Series H preferred share of beneficial interest, $0.4297 per Series I preferred share of beneficial interest, and $0.4563 per Series I-1 preferred unit of Preferred Limited Partnership Interest. Each of the cash dividends on these preferred shares and preferred units is payable on April 16, 2018 to shareholders and operating partnership unit holders of record on March 29, 2018.
About Washington Prime Group
Washington Prime Group Inc. is a retail REIT and a recognized leader in the ownership, management, acquisition and development of retail properties. The Company combines a national real estate portfolio with an investment grade balance sheet, leveraging its expertise across the entire shopping center sector to increase cash flow through rigorous management of assets and provide new opportunities to retailers looking for growth throughout the U.S. Washington Prime Group® is a registered trademark of the Company. Learn more at www.washingtonprime.com.
Contact
Kimberly A. Green, VP, Investor Relations & Corporate Communications, 614.887.5647 or [email protected]


Samsung Electronics Shares Jump on HBM4 Mass Production Report
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence 



